insights_auto
Kwa nini SOBI imepungua kwa 3.30%?
Fahamu zaidichevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 480.20
arrow_downward
-3.30%(-16.40) Siku 1
10 Nov, 17:29:32 GMT +1 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya SOBI...
Fungua
SEK 485.00
Juu
SEK 493.40
Chini
SEK 476.80
Mtaji wa soko
171.74B
Wastani wa kiasi cha mauzo
elfu 361.32
Kiasi cha mauzo ya hisa
elfu 717.56
Uwiano wa bei ya hisa na mapato kwa kila hisa
25.51
Juu kwa wiki 52
SEK 507.00
Chini kwa wiki 52
SEK 314.40
EPS
SEK 18.83
Hisa za wawekezaji
357.64M
Idadi ya wafanyakazi
elfu 2
Fungua
SEK 485.00
Juu
SEK 493.40
Chini
SEK 476.80
Mtaji wa soko
171.74B
Wastani wa kiasi cha mauzo
elfu 361.32
Kiasi cha mauzo ya hisa
elfu 717.56
Uwiano wa bei ya hisa na mapato kwa kila hisa
25.51
Juu kwa wiki 52
SEK 507.00
Chini kwa wiki 52
SEK 314.40
EPS
SEK 18.83
Hisa za wawekezaji
357.64M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
FOREX.com
·
dakika 55 zilizopita
S&P 500 forecast: tech rebound faces CPI test | Technical Tuesday
BigGo Finance
·
saa 2 zilizopita
UBS Sees S&P 500 at 8,900 by End-2027 as BofA Flags Crowded Index Trade
Eurasia Business News
·
saa 5 zilizopita
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Fall on November 10, 2026; Oil and Gold Retreat
The Motley Fool
·
saa 3 zilizopita
S&P 500 Sell-Off: 1 Investing Step to Take Right Now, and 1 Risky Move to Avoid
Wasifu
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Kuhusu Swedish Orphan Biovitrum AB (publ)
Afisa Mkuu Mtendaji (CEO)Guido Oelkers
Wafanyakazielfu 2.21
Lilianzishwa1939
Makao makuu-
SektaHealth Care
Sekta-
Tovutisobi.com